Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies.

Laruelle M, Abi-Dargham A.

J Psychopharmacol. 1999 Dec;13(4):358-71. Review.

PMID:
10667612
2.

Increased dopamine transmission in schizophrenia: relationship to illness phases.

Laruelle M, Abi-Dargham A, Gil R, Kegeles L, Innis R.

Biol Psychiatry. 1999 Jul 1;46(1):56-72. Review.

PMID:
10394474
3.

Imaging dopamine transmission in schizophrenia. A review and meta-analysis.

Laruelle M.

Q J Nucl Med. 1998 Sep;42(3):211-21. Review.

PMID:
9796369
4.

Applications of SPECT imaging of dopaminergic neurotransmission in neuropsychiatric disorders.

Kugaya A, Fujita M, Innis RB.

Ann Nucl Med. 2000 Feb;14(1):1-9. Review.

PMID:
10770574
5.
6.

The role of dopamine for the pathophysiology of schizophrenia.

Meisenzahl EM, Schmitt GJ, Scheuerecker J, Möller HJ.

Int Rev Psychiatry. 2007 Aug;19(4):337-45. Review.

PMID:
17671867
7.

Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review.

Laruelle M.

J Cereb Blood Flow Metab. 2000 Mar;20(3):423-51. Review.

PMID:
10724107
8.

Neurochemical brain imaging investigations of schizophrenia.

Soares JC, Innis RB.

Biol Psychiatry. 1999 Sep 1;46(5):600-15. Review.

PMID:
10472414
9.

[Neuroimaging in schizophrenia].

Lanzenberger R, Kasper S.

Fortschr Neurol Psychiatr. 2005 Nov;73 Suppl 1:S51-9. Review. German.

PMID:
16270245
10.

Utilization of radioligands in schizophrenia research.

Sedvall G, Farde L, Hall H, Halldin C, Karlsson P, Nordström AL, Nyberg S, Pauli S.

Clin Neurosci. 1995;3(2):112-21. Review.

PMID:
7583617
11.

The current status of PET scanning with respect to schizophrenia.

Sedvall G.

Neuropsychopharmacology. 1992 Aug;7(1):41-54. Review.

PMID:
1388021
12.

Recent developments in PET scan imaging of neuroreceptors in schizophrenia.

Sedvall G, Pauli S, Farde L, Karlsson P, Nyberg S, Nordström AL.

Isr J Psychiatry Relat Sci. 1995;32(1):22-9. Review.

PMID:
7622344
13.

Neurochemical imaging in schizophrenia.

Urban N, Abi-Dargham A.

Curr Top Behav Neurosci. 2010;4:215-42. Review.

PMID:
21312402
14.

Pathway-Specific Dopamine Abnormalities in Schizophrenia.

Weinstein JJ, Chohan MO, Slifstein M, Kegeles LS, Moore H, Abi-Dargham A.

Biol Psychiatry. 2017 Jan 1;81(1):31-42. doi: 10.1016/j.biopsych.2016.03.2104. Epub 2016 Mar 31. Review.

PMID:
27206569
15.

Structural and functional brain imaging in schizophrenia.

Cleghorn JM, Zipursky RB, List SJ.

J Psychiatry Neurosci. 1991 Jul;16(2):53-74. Review.

16.

Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder--implications for psychopharmacology.

Kasper S, Tauscher J, Willeit M, Stamenkovic M, Neumeister A, Küfferle B, Barnas C, Stastny J, Praschak-Rieder N, Pezawas L, de Zwaan M, Quiner S, Pirker W, Asenbaum S, Podreka I, Brücke T.

World J Biol Psychiatry. 2002 Jul;3(3):133-46. Review.

PMID:
12478878
17.

Dopamine receptor classification, neuroanatomical distribution and in vivo imaging.

Brücke T, Wenger S, Podreka I, Asenbaum S.

Wien Klin Wochenschr. 1991;103(21):639-46. Review.

PMID:
1771898
18.

Positron emission tomography and single photon emission CT molecular imaging in schizophrenia.

Erritzoe D, Talbot P, Frankle WG, Abi-Dargham A.

Neuroimaging Clin N Am. 2003 Nov;13(4):817-32. Review.

PMID:
15024964
19.

[Investigation of the dopamine dysregulation hypothesis of schizophrenia with neuroimaging techniques].

Szekeres G, Pávics L, Janka Z.

Ideggyogy Sz. 2002 Jul 20;55(7-8):226-32. Review. Hungarian.

PMID:
12201230
20.

Monoamines and schizophrenia.

Sedvall G.

Acta Psychiatr Scand Suppl. 1990;358:7-13. Review.

PMID:
1978495

Supplemental Content

Support Center